These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23599531)

  • 1. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
    Kiss G; Lacour A; d'Hollander A
    Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
    Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
    Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex in patients with myasthenia gravis.
    De Boer HD; Van Egmond J; Driessen JJ; Booij LHJD
    Anaesthesia; 2010 Jun; 65(6):653. PubMed ID: 20565409
    [No Abstract]   [Full Text] [Related]  

  • 5. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].
    Komasawa N; Noma H; Sugi T; Sukenaga N; Kakiuchi H
    Masui; 2011 Apr; 60(4):476-9. PubMed ID: 21520600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
    Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex].
    Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H
    Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
    Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
    Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is one acceleromyographically measured train-of-four ratio sufficient after sugammadex to identify residual curarization in postoperative, awake patients?
    Unterbuchner C
    Br J Anaesth; 2016 Mar; 116(3):433-4. PubMed ID: 26865139
    [No Abstract]   [Full Text] [Related]  

  • 12. Sugammadex and rescue reversal.
    Mirakhur RK; Shields MO; de Boer HD
    Anaesthesia; 2011 Feb; 66(2):140-1; author reply 141. PubMed ID: 21254995
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of sugammadex in a patient with myasthenia gravis].
    Challan Belval A; Tramoni G; Vedrinne JM; Olagne E; Vigneron M
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):569-70. PubMed ID: 22677058
    [No Abstract]   [Full Text] [Related]  

  • 14. Sugammadex and residual neuromuscular block: what is acceptable normal practice?
    Todd MM
    Br J Anaesth; 2016 Mar; 116(3):434-5. PubMed ID: 26865140
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis.
    Jakubiak J; Gaszyński T; Gaszyński W
    Anaesthesiol Intensive Ther; 2012; 44(1):28-30. PubMed ID: 23801510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
    Suzuki T; Kitajima O; Ueda K; Kondo Y; Kato J; Ogawa S
    Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.